Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants.
Intensive chemoradiotherapy damages the mucosal barrier of the mouth and throat and is often associated with severe oral inflammation and infection. This study examined the use of a 0.12% chlorhexidine gluconate mouthrinse for prophylaxis against oral complications in patients receiving bone marrow transplants. Use of chlorhexidine mouthrinse produced reductions in oral soft tissue disease and oral microbial burden, including a significant decrease in oral mucositis and Candida infections. The advantage for patients undergoing intensive antineoplastic therapy, and potentially for other immunocompromised patients susceptible to oral infections, was studied.
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002180:Candidiasis, Oral / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use*; D003773:Dental Plaque / Q000517:prevention & control; D004311:Double-Blind Method; D005891:Gingivitis / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D008875:Middle Aged; D009059:Mouth Diseases / Q000517:prevention & control*; D009067:Mouthwashes; D011446:Prospective Studies; D011897:Random Allocation; D013280:Stomatitis / Q000517:prevention & control; D013291:Streptococcus / Q000187:drug effects / Q000302:isolation & purification
D009067:Mouthwashes; D002710:Chlorhexidine